Is there an increased risk of lymphoma and malignancies under anti-TNF therapy in IBD?

@article{Lakatos2010IsTA,
  title={Is there an increased risk of lymphoma and malignancies under anti-TNF therapy in IBD?},
  author={Peter L Lakatos and P{\'a}l Miheller},
  journal={Current drug targets},
  year={2010},
  volume={11 2},
  pages={
          179-86
        }
}
Tumour necrosis factor alpha (TNF-alpha) inhibitors ensure valuable treatment advantages for patients with inflammatory bowel diseases (IBD) by offering a more targeted anti-inflammatory therapy. In contrast, there is concern that it might increase the risk of long-term complications including infections and the risk for malignancies and non-Hodgkin's lymphoma (NHL). Although the results from hospital- and population-based studies are conflictive, the results of a meta-analysis suggest that… CONTINUE READING
17 Extracted Citations
0 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 17 extracted citations

Similar Papers

Loading similar papers…